- Home
- SPB vs HCM Comparison
SPB vs HCM Comparison
Compare SPB & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPB | HCM |
|---|---|---|
| Founded | 1906 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1796 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPB | HCM |
|---|---|---|
| Price | $88.68 | $10.95 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $82.40 | $13.75 |
| AVG Volume (30 Days) | ★ 309.0K | 50.9K |
| Earning Date | 05-07-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $3,802,100,000.00 | N/A |
| Revenue This Year | $2.03 | $20.60 |
| Revenue Next Year | $1.85 | $15.62 |
| P/E Ratio | $40.48 | ★ $5.49 |
| Revenue Growth | ★ 20.86 | N/A |
| 52 Week Low | $49.99 | $9.77 |
| 52 Week High | $90.60 | $19.50 |
Technical Indicators
Market Signals| Indicator | SPB | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 57.14 | 46.80 |
| Support Level | $80.58 | $10.83 |
| Resistance Level | $90.60 | $11.80 |
| Average True Range (ATR) | 2.59 | 0.22 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 70.80 | 11.98 |
Price Performance
Historical ComparisonAbout SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.